Quetiapine fumarate and Taste disturbance - a phase IV clinical study of FDA data

Summary:

Taste disturbance is reported only by a few people who take Quetiapine Fumarate.

The phase IV clinical study analyzes which people take Quetiapine fumarate and have Taste disturbance. It is created by eHealthMe based on reports of 21,851 people who have side effects while taking Quetiapine fumarate from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 28, 2022

21,851 people reported to have side effects when taking Quetiapine fumarate.
Among them, 2 people (0.01%) have Taste disturbance.

What is Quetiapine fumarate?

Quetiapine fumarate has active ingredients of quetiapine fumarate. It is often used in insomnia. eHealthMe is studying from 22,814 Quetiapine fumarate users for its effectiveness, alternative drugs and more.

What is Taste disturbance?

Taste disturbance is found to be associated with 1,001 drugs and 2 conditions by eHealthMe.

Number of Quetiapine fumarate and Taste disturbance reports submitted per year:

Could Quetiapine fumarate cause Taste disturbance?

Gender of people who have Taste disturbance when taking Quetiapine fumarate *:

female: 50 %
male: 50 %

Age of people who have Taste disturbance when taking Quetiapine fumarate *:

Common drugs people take besides Quetiapine fumarate *:

Zolpidem: 1 person, 50.00%
Pepcid: 1 person, 50.00%
Mirtazapine: 1 person, 50.00%
Hydroxyzine: 1 person, 50.00%
Celebrex: 1 person, 50.00%

Common side effects people have besides Taste disturbance *:

Sweating Increased (excess sweating): 1 person, 50.00%
Pupil Fixed: 1 person, 50.00%
Pulse Absent: 1 person, 50.00%
Nausea (feeling of having an urge to vomit): 1 person, 50.00%
Left Ventricular Failure (left ventricle fails to contract forcefully): 1 person, 50.00%
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch): 1 person, 50.00%
Heart Attack: 1 person, 50.00%
Hair Loss: 1 person, 50.00%
Face Oedema (swelling of face): 1 person, 50.00%
Confusion: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Quetiapine fumarate and have Taste disturbance?

Check whether Taste disturbance is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
Shah Z, Londhe V, "Influence of various media on the dissolution profiles of immediate-release quetiapine tablets in India", Dissolution Technologies, 2016 Feb .

Related studies

Common Quetiapine fumarate side effects:

Drug ineffective: 2,113 reports
Fatigue (feeling of tiredness): 1,306 reports
Depression: 1,146 reports
Stress and anxiety: 1,060 reports
Dizziness: 956 reports
Drowsiness: 929 reports

Browse all side effects of Quetiapine fumarate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Taste disturbance treatments and more:

Taste disturbance (4,340 reports)

COVID vaccines that are related to Taste disturbance:

Common drugs associated with Taste disturbance:

All the drugs that are associated with Taste disturbance:

Taste disturbance (1,001 drugs)

All the conditions that are associated with Taste disturbance:

Taste disturbance (2 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on quetiapine fumarate (the active ingredients of Quetiapine fumarate) and Quetiapine fumarate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.